Literature DB >> 19546191

Functional and immunological characterization of a Duffy binding-like alpha domain from Plasmodium falciparum erythrocyte membrane protein 1 that mediates rosetting.

Alfredo Mayor1, Eduard Rovira-Vallbona, Anand Srivastava, Surya K Sharma, Sudhanshu S Pati, Laura Puyol, Llorenç Quinto, Quique Bassat, Sonia Machevo, Inacio Mandomando, Virander S Chauhan, Pedro L Alonso, Chetan E Chitnis.   

Abstract

The Duffy binding-like (DBL) domains are common adhesion modules present in Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) variants, which are responsible for immune evasion and cytoadherence. Knowledge about how immune responses are acquired against polymorphic DBL domains of PfEMP1 can aid in the development of vaccines for malaria. A recombinant DBLalpha domain, encoded by R29 var1, which binds complement receptor 1 to mediate rosetting by the P. falciparum laboratory strain R29, was expressed in Escherichia coli, renatured by oxidative refolding to its native form, and purified to homogeneity. Antibody levels in 704 plasmas obtained from residents of areas of different levels of malaria endemicity in Orissa (India) and Manhiça (Mozambique) were assessed by enzyme-linked immunosorbent assay. The refolded DBLalpha domain was pure, homogeneous, and functional in that it bound human erythrocytes with specificity and was capable of inhibiting rosetting. The proportion of individuals who had measurable anti-DBLalpha immunoglobulin G responses was low in areas of low malaria endemicity in Orissa (6.7%) but high in areas of high endemicity in Orissa (87.5%) and Manhiça (74.5%). Seroprevalence and antibody levels against the recombinant protein increased with the age of inhabitants from areas with high transmission rates (P < 0.001). Half of the children in these areas had seroconverted by the age of 5 years. These findings suggest that in spite of the extreme polymorphism of PfEMP1 DBLalpha domains, the acquisition of specific antibodies is rapid and age related and reflects the reduced risk of malaria in areas with high transmission rates. Further studies are required to elucidate the role of these antibodies in protection from malaria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19546191      PMCID: PMC2738012          DOI: 10.1128/IAI.00049-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family.

Authors:  J D Smith; G Subramanian; B Gamain; D I Baruch; L H Miller
Journal:  Mol Biochem Parasitol       Date:  2000-10       Impact factor: 1.759

2.  Biochemical, biophysical, and functional characterization of bacterially expressed and refolded receptor binding domain of Plasmodium vivax duffy-binding protein.

Authors:  S Singh; K Pandey; R Chattopadhayay; S S Yazdani; A Lynn; A Bharadwaj; A Ranjan; C Chitnis
Journal:  J Biol Chem       Date:  2001-03-13       Impact factor: 5.157

3.  Antibodies to variable Plasmodium falciparum-infected erythrocyte surface antigens are associated with protection from novel malaria infections.

Authors:  H A Giha; T Staalsoe; D Dodoo; C Roper; G M Satti; D E Arnot; L Hviid; T G Theander
Journal:  Immunol Lett       Date:  2000-02-01       Impact factor: 3.685

4.  High prevalence of human antibodies to recombinant Duffy binding-like alpha domains of the Plasmodium falciparum-infected erythrocyte membrane protein 1 in semi-immune adults compared to that in nonimmune children.

Authors:  R M Oguariri; S Borrmann; M Q Klinkert; P G Kremsner; J F Kun
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

Review 5.  The pathogenic basis of malaria.

Authors:  Louis H Miller; Dror I Baruch; Kevin Marsh; Ogobara K Doumbo
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

6.  Impact of intermittent preventive treatment with sulfadoxine-pyrimethamine on antibody responses to erythrocytic-stage Plasmodium falciparum antigens in infants in Mozambique.

Authors:  Diana Quelhas; Laura Puyol; Llorenç Quintó; Elisa Serra-Casas; Tacilta Nhampossa; Eusebio Macete; Pedro Aide; Alfredo Mayor; Inacio Mandomando; Sergi Sanz; John J Aponte; Virander S Chauhan; Chetan E Chitnis; Pedro L Alonso; Clara Menéndez; Carlota Dobaño
Journal:  Clin Vaccine Immunol       Date:  2008-05-21

7.  Plasmodium falciparum infection elicits both variant-specific and cross-reactive antibodies against variant surface antigens.

Authors:  Rana Chattopadhyay; Amit Sharma; Vinod K Srivastava; Sudhanshu S Pati; S K Sharma; Bhabani S Das; Chetan E Chitnis
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

Review 8.  var genes, PfEMP1 and the human host.

Authors:  Kirsten Flick; Qijun Chen
Journal:  Mol Biochem Parasitol       Date:  2004-03       Impact factor: 1.759

9.  Recombinant Duffy binding-like-alpha domains of Plasmodium falciparum erythrocyte membrane protein 1 elicit antibodies in rats that recognise conserved epitopes.

Authors:  Raphael M Oguariri; Denise Mattei; Cristina Tena-Tomás; Anne-Catrin Uhlemann; Peter G Kremsner; Jürgen F J Kun
Journal:  Parasitol Res       Date:  2003-06-12       Impact factor: 2.289

10.  Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia.

Authors:  Brenda A Okech; Patrick H Corran; James Todd; Amy Joynson-Hicks; Chairat Uthaipibull; Thomas G Egwang; Anthony A Holder; Eleanor M Riley
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

View more
  20 in total

1.  Infectious disease: Pathogenesis of cerebral malaria-a step forward.

Authors:  Sudhanshu S Pati; Saroj K Mishra
Journal:  Nat Rev Neurol       Date:  2012-07-24       Impact factor: 42.937

Review 2.  Malaria evolution in South Asia: knowledge for control and elimination.

Authors:  Krishnamoorthy Narayanasamy; Laura Chery; Analabha Basu; Manoj T Duraisingh; Ananias Escalante; Joseph Fowble; Jennifer L Guler; Thurston Herricks; Ashwani Kumar; Partha Majumder; Jennifer Maki; Anjali Mascarenhas; Janneth Rodrigues; Bikram Roy; Somdutta Sen; Jayanthi Shastri; Joseph Smith; Neena Valecha; John White; Pradipsinh K Rathod
Journal:  Acta Trop       Date:  2012-01-14       Impact factor: 3.112

3.  IgG antibodies to endothelial protein C receptor-binding cysteine-rich interdomain region domains of Plasmodium falciparum erythrocyte membrane protein 1 are acquired early in life in individuals exposed to malaria.

Authors:  Louise Turner; Thomas Lavstsen; Bruno P Mmbando; Christian W Wang; Pamela A Magistrado; Lasse S Vestergaard; Deus S Ishengoma; Daniel T R Minja; John P Lusingu; Thor G Theander
Journal:  Infect Immun       Date:  2015-05-26       Impact factor: 3.441

4.  Development of quantitative suspension array assays for six immunoglobulin isotypes and subclasses to multiple Plasmodium falciparum antigens.

Authors:  Marta Vidal; Ruth Aguilar; Joseph J Campo; Carlota Dobaño
Journal:  J Immunol Methods       Date:  2018-01-31       Impact factor: 2.303

5.  The humoral response to Plasmodium falciparum VarO rosetting variant and its association with protection against malaria in Beninese children.

Authors:  Inès Vigan-Womas; Adjimon Lokossou; Micheline Guillotte; Alexandre Juillerat; Graham Bentley; André Garcia; Odile Mercereau-Puijalon; Florence Migot-Nabias
Journal:  Malar J       Date:  2010-10-05       Impact factor: 2.979

6.  How specific is Plasmodium falciparum adherence to chondroitin 4-sulfate?

Authors:  Suchi Goel; D Channe Gowda
Journal:  Trends Parasitol       Date:  2011-04-18

7.  Low antibodies against Plasmodium falciparum and imbalanced pro-inflammatory cytokines are associated with severe malaria in Mozambican children: a case-control study.

Authors:  Eduard Rovira-Vallbona; Gemma Moncunill; Quique Bassat; Ruth Aguilar; Sonia Machevo; Laura Puyol; Llorenç Quintó; Clara Menéndez; Chetan E Chitnis; Pedro L Alonso; Carlota Dobaño; Alfredo Mayor
Journal:  Malar J       Date:  2012-05-30       Impact factor: 2.979

8.  Cytokine and antibody responses to Plasmodium falciparum in naïve individuals during a first malaria episode: effect of age and malaria exposure.

Authors:  Gemma Moncunill; Alfredo Mayor; Alfons Jiménez; Augusto Nhabomba; Laura Puyol; Maria N Manaca; Diana Barrios; Pau Cisteró; Caterina Guinovart; Ruth Aguilar; Azucena Bardají; María-Jesús Pinazo; Evelina Angov; Sheetij Dutta; Chetan E Chitnis; José Muñoz; Joaquim Gascón; Carlota Dobaño
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

9.  Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum.

Authors:  Ashfaq Ghumra; Pongsak Khunrae; Ricardo Ataide; Ahmed Raza; Stephen J Rogerson; Matthew K Higgins; J Alexandra Rowe
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

10.  Allelic diversity of the Plasmodium falciparum erythrocyte membrane protein 1 entails variant-specific red cell surface epitopes.

Authors:  Inès Vigan-Womas; Micheline Guillotte; Alexandre Juillerat; Cindy Vallieres; Anita Lewit-Bentley; Adama Tall; Laurence Baril; Graham A Bentley; Odile Mercereau-Puijalon
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.